1[1]Braunwald's Heart Disease.6th edition. USA: W. B. Saunders Company, 2001.
2[3]Carville DG, Dimitrijevic N,Walsh M, et al. Thrombus precursor protein(TpP):marker of thrombrosis early in the pathogenesis of myocardial infarction [J].Clin Chem,1996,42(9):1537-1540.
4[6]Nader Rifai,Paul M Ridker. High-sensitivity C-reactive protein:a novel and Promising marker of coronary heart disease[J].Clin Chem,2001,47:403-411.
5HenneyA M,WakeleyP R,DaviesM J,et al.L ocation ofstromelysin gene expression in atherosclerotic plaque by in situhybridization〔J〕[].Proceedings of the National Academy of Sciences of the United States of America.1991
6Yam adaY,IzawaH,IchiharaS,et al.Prediction of the risk ofmyocardial infarction from polymorphism in candidate genes〔J〕[].The New England Journal of Medicine.2002
7SchwarzA,HaberboschW,TillmannsH,etal.The strom elysin15A/6A promoter polymorphism is a disease marker for theextent of coronary heart disease〔J〕[].Disease Markers.2002
8ZukerS,HymowitzM,ConnerC,et al.Measurem ent of m atrixmetalloproteinase and tissue inhibition of metalloproteinase inblood and tissue〔J〕[].AnnN Y AcadSci.1999
9Steve E. Humphries Le-Anh Luong Philippa J. Talmud M. Heikki Frick Y. Antero Kesiemi Amos Pasternack Marja-Riitta Taskinen and Mikko Syvne.The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study[].Atherosclerosis.1998
10Terashima M,Akita H,Kanazawa K,et al.Stromelysin promoter 5A 6A polymorphism is association with acute myocardial infarction[].Circulation.1999
4Yoshihara F,Nishikimi T,Okano I,et al.Upregulation of intracardiac adrenomedullin and its receptor system in rats with volume overload-induced cardiac hypertrophy[J].Regul Pept,2005,127(1-3):239-244.
5Candia AM,Villacorta H Jr,Mesquita ET.Immune-inflammatory activation in heart failure[J].Arq Bras Cardiol,2007,89(3):183-190,201-208.
6Rutschow S,Li J,Schultheiss HP,et al.Myocardial proteases and matrix remodeling in inflammatory heart disease[J].Cardiovasc Res,2006,69(3):646-656.
7Dai RP,Dheen ST,He BP,et al.Differential expression of cytokines in the rat heart in response to sustained volume overload[J].Eur J Heart Fail,2004,6(6):693-703.
8Jugdutt BI,Idikio H,Uwiera RR.Angiotensin receptor blockade and angiotensin converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction[J].Mol Cell Biochem,2007,303(1-2):27-38.
9Spinale FG.Myocardial matrix remodeling and the matrix metalloproteinases:influence on cardiac form and function[J].Physiol Rev,2007,87(4):1285-1342.
10Kitaoka H,Kubo T,Okawa M,et al.Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy[J].Circ J,2010,74(6):1191-1196.
